Find your next paid study

National Institute of Neurological Disorders and Stroke (NINDS)NCT07796360

~$10 – $5,625

Observational

EVERYVET (Empowering VEterans in Research effectivelY Using Virtual Engagement Tools): A Patient-Centered Study

Cardiovascular disease is the leading cause of death among Veterans. Clinical trials are essential for developing better treatments, but Veterans remain underr…

Atrial Fibrillation (AF)Cardiovascular Diseases

VA Office of Research and DevelopmentNCT07741955

~$10 – $5,625

Evaluating the Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients: A 24-Week Study

The purpose of this study is to evaluate the effectiveness of lebrikizumab in treating adults with moderate-to-severe Prurigo Nodularis (PN).

Prurigo Nodularis (PN)

University of Maryland, BaltimoreNCT07620561

~$10 – $6,250

Glioblastoma, IDH-Wildtype

Randomized Phase II Trial to Evaluate the Efficacy of WSD0922-FU When Combined With Adjuvant Temozolomide in Patients With EGFR Mutant Glioblastoma

This phase II trial compares the effect of adding WSD0922-FU to temozolomide versus temozolomide alone in slowing disease progression in patients with Epiderma…

~$10 – $6,250

Mayo ClinicNCT07708961

HypertriglyceridemiaSevere Hypertriglyceridemia

A Phase 2, Open-label Trial Evaluating the Safety, Tolerability and Efficacy of ION775 in Adults With Hypertriglyceridemia

The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and se…

Ionis Pharmaceuticals, Inc.NCT07604974

Phase 1

A Phase 1/2 Clinical Study to Evaluate Safety, Tolerability, Biological Activity, and Initial Efficacy of Prime Editing (PM577a) for the Treatment of Wilson Disease (WD) in Adult and Adolescent Participants With at Least One Allele Harboring the p.H1069Q Mutation in ATP7B

The purpose of this study is to evaluate the safety, tolerability, biological activity, and initial efficacy of PM577a, an investigational Prime Editing therap…

Wilson DiseaseWilson's DiseaseWilsons Disease

Prime Medicine, Inc.NCT07748403

Crohn's DiseaseUlcerative Colitis

A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, swelling) i…

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in Patients With Relapsed/Refractory Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (T-RRex)

The T-RRex study evaluates the efficacy of WU-CART-007 for patients with Relapsed/Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL)/Lymphoblastic Ly…

T-cell Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma

Allotera TherapeuticsNCT06514794

Phase 4

A Phase 4, Prospective, Open-Label, Single Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight in Clinical Practice

The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with mo…

PsoriasisOverweight or Obesity

Eli Lilly and CompanyNCT06857942

~$10 – $7,500

Recurrent Langerhans Cell HistiocytosisRefractory Langerhans Cell Histiocytosis

Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis

This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that…

National Cancer Institute (NCI)NCT05828069

~$10 – $5,625

Phase 3

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled Clinical Trial of Titrating Doses of PP-01 for the Mitigation of Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder: Core Study With Safety Extension Phase

This study is a randomized, double-blind, placebo and active-controlled, multicenter trial conducted to evaluate whether PP-01 mitigates the withdrawal symptom…

Cannabis Withdrawal

PleoPharma, Inc.NCT07644052

Observational

Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions (Component 3)

This study will assess the benefits of using mobile health system designed for individuals with chronic and complex health conditions (such as those with Spina…

Spinal Cord InjuriesCerebral PalsySpinal Dysraphism+3 more